Affordable Access

Publisher Website

ATP Release Mechanisms of Endothelial Cell–Mediated Stimulus-Dependent Hyperalgesia

Authors
Journal
Journal of Pain
1526-5900
Publisher
Elsevier
Identifiers
DOI: 10.1016/j.jpain.2014.04.005
Keywords
  • Endothelin-1
  • Adenosine Triphosphate Release
  • Vascular Pain
  • Endothelium

Abstract

Abstract Endothelin-1 (ET-1) acts on endothelial cells to enhance mechanical stimulation–induced release of adenosine triphosphate (ATP), which in turn can act on sensory neurons innervating blood vessels to contribute to vascular pain, a phenomenon we have referred to as stimulus-dependent hyperalgesia (SDH). In the present study, we evaluated the role of the major classes of ATP release mechanisms to SDH: vesicular exocytosis, plasma membrane–associated ATP synthase, ATP-binding cassette transporters, and ion channels. Inhibitors of vesicular exocytosis (ie, monensin, brefeldin A, and bafilomycin), plasma membrane–associated ATPase (ie, oligomycin and pigment epithelium–derived factor peptide 34-mer), and connexin ion channels (carbenoxolone and flufenamic acid) but not ATP-binding cassette transporter (ie, dipyridamole, nicardipine, or CFTRinh-172) attenuated SDH. This study reports a role of ATP in SDH and suggests novel targets for the treatment of vascular pain syndromes. Perspective ET-1 acts on endothelial cells to produce mechanical stimulation–induced hyperalgesia. Inhibitors of 3 different ATP release mechanisms attenuated this SDH. This study provides support for a role of ATP in SDH and suggests novel targets for the treatment of vascular pain syndromes.

There are no comments yet on this publication. Be the first to share your thoughts.